| Indicators | Browse All

Drugs Made In America Acquisition II Corp. (DMII)

Financial Services | Shell Companies | New York, United States | NasdaqGM
10.09 USD

Short-term:★★⯪☆☆Long-term:★★⯪☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 4:25 a.m. EDT

The security is a shell company with no operating business, generating negative operating cash flow and holding negative book value, which fundamentally disqualifies it from being a long-term investment despite the high model confidence in its short-term price noise. While the statistical forecast indicates a very high probability of a slight price increase over the next 45 days, this reflects trading volatility around a $10 IPO price rather than any underlying economic value or growth potential. With no dividend history and a lack of meaningful price trajectory data due to its status as a pre-merger entity, there is no rational basis for a bullish stance beyond the immediate technical range-bound behavior typical of SPACs awaiting a deal.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.001188
AutoTheta0.002683
MSTL_150.004251
AutoETS0.004538
MSTL0.004583

Forecast horizon: 60 days | Selected: AutoARIMA

Forecast Reliability
Score 87%
H-stat 1.60
Ljung-Box p 0.000
Jarque-Bera p 0.486
Excess Kurtosis -0.76
Attribute Value
Sector Financial Services
Market Cap 642,732,992
Trailing P/E 77.62

Info Dump

Attribute Value
52 Week Change 0.022267222
Address1 420 Lexington Avenue
Address2 Suite 1402
All Time High 10.11
All Time Low 9.86
Ask 10.04
Ask Size 2
Average Daily Volume10 Day 34,110
Average Daily Volume3 Month 128,091
Average Volume 128,091
Average Volume10Days 34,110
Bid 10.08
Bid Size 1
Book Value -0.28
City New York
Country United States
Crypto Tradeable 0
Currency USD
Current Price 10.09
Current Ratio 0.528
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 10.09
Day Low 10.09
Display Name Drugs Made In America Acquisition II
Ebitda Margins 0.0
Enterprise Value 642,835,264
Eps Trailing Twelve Months 0.13
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 10.06112
Fifty Day Average Change 0.02888012
Fifty Day Average Change Percent 0.0028704677
Fifty Two Week Change Percent 2.2267222
Fifty Two Week High 10.11
Fifty Two Week High Change -0.019999504
Fifty Two Week High Change Percent -0.0019781904
Fifty Two Week Low 9.86
Fifty Two Week Low Change 0.2300005
Fifty Two Week Low Change Percent 0.023326622
Fifty Two Week Range 9.86 - 10.11
Financial Currency USD
First Trade Date Milliseconds 1,764,772,200,000
Float Shares 50,258,026
Full Exchange Name NasdaqGM
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Held Percent Insiders 0.15215
Held Percent Institutions 0.70442003
Implied Shares Outstanding 63,700,000
Industry Shell Companies
Industry Disp Shell Companies
Industry Key shell-companies
Ipo Expected Date 2,025-12-03
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.
Long Name Drugs Made In America Acquisition II Corp.
Market us_market
Market Cap 642,732,992
Market State PREPRE
Max Age 86,400
Message Board Id finmb_1938104325
Most Recent Quarter 1,774,915,200
Net Income To Common 8,584,197
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 643,370,000
Open 10.09
Operating Cashflow -1,110,690
Operating Margins 0.0
Payout Ratio 0.0
Phone 917 982 4565
Previous Close 10.09
Price Hint 2
Price To Book -36.035713
Profit Margins 0.0
Quick Ratio 0.522
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.0
Regular Market Change Percent 0.0
Regular Market Day High 10.09
Regular Market Day Low 10.09
Regular Market Day Range 10.09 - 10.09
Regular Market Open 10.09
Regular Market Previous Close 10.09
Regular Market Price 10.09
Regular Market Time 1,783,972,800
Regular Market Volume 1,838
Sand P52 Week Change 0.20847368
Sector Financial Services
Sector Disp Financial Services
Sector Key financial-services
Shares Outstanding 63,700,000
Shares Percent Shares Out 0.00090000004
Shares Short 58,818
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 65,009
Short Name Drugs Made In America Acquisiti
Short Percent Of Float 0.001
Short Ratio 0.57
Source Interval 15
State NY
Symbol DMII
Total Cash 347,720
Total Cash Per Share 0.005
Total Debt 450,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps 0.13
Trailing P E 77.61539
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 9.991007
Two Hundred Day Average Change 0.0989933
Two Hundred Day Average Change Percent 0.009908241
Type Disp Equity
Volume 1,838
Zip 10,170